1,784 results on '"Roberts, Lewis R."'
Search Results
152. Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis
153. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence
154. Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival
155. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
156. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma
157. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States
158. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
159. Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
160. Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
161. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
162. A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection
163. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
164. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment
165. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
166. Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease.
167. HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data
168. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk
169. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
170. Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana
171. DEVELOPMENT AND VALIDATION OF A CYTOLOGY-BASED DEEP LEARNING ARTIFICIAL INTELLIGENCE MODEL FOR DIAGNOSING BILIARY TRACT MALIGNANCIES
172. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
173. Su1336: TREATMENT INITIATION AND OUTCOMES OF AFRICAN AMERICANS AND NON-AFRICAN AMERICANS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
174. EP1203: ASSOCIATION OF METABOLIC HEALTH PHENOTYPES AND HEPATOCELLULAR CARCINOMA RISK
175. 949: PROGNOSTIC LIVER SECRETOME SIGNATURE AND ALPHA-FETOPROTEIN (PLSEC-AFP) PREDICTS LONG-TERM HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CIRRHOSIS: A NATIONWIDE PHASE 3 BIOMARKER STUDY IN THE U.S.
176. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis
177. 528: THE MULTI-TARGET HEPATOCELLULAR CARCINOMA BLOOD TEST PROVIDES HIGH SENSITIVITY FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA ACROSS IMPORTANT PATIENT SUBGROUPS
178. 950: REAL-WORLD EFFECTIVENESS AND RACIAL/ETHNIC DISPARITIES IN IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA: ANALYSIS OF US NATIONAL CANCER DATABASE
179. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
180. 330 DIAGNOSTIC PERFORMANCE OF FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR BILIARY STRICTURES: DOES THE DEFINITION MATTER?
181. Su1167 SERUM PSEUDOCHOLINESTERASE LEVEL AS A PROGNOSTIC BIOMARKER IN HEPATOCELLULAR CARCINOMA
182. Su1122 TIME TO DIAGNOSIS AND DIAGNOSTIC DELAY IN PATIENTS WITH EXTRAHEPATIC CHOLANGIOCARCINOMA
183. Tu1582 CHOLANGIOCARCINOMA INCIDENCE AND SURVIVAL: A STUDY OF CONTRIBUTING FACTORS AND MORTALITY PREDICTORS
184. Tu1560 DIAGNOSTIC PERFORMANCE OF OPTIMIZED PANCREATOBILIARY FLUORESCENCE IN SITU HYBRIDIZATION (PB-FISH) IN EVALUATION OF BILIARY STRICTURES.
185. 1052 PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S.
186. Mo1473 PREVALENCE OF RARE GERMLINE VARIANTS IN HEPATOCELLULAR CARCINOMA IN A GLOBAL MULTI-ETHNIC CASE-CONTROL GENETIC ASSOCIATION STUDY
187. Mo1189 CLOUD OF SUSPICION: DEFINING THE PREVALENCE OF MALIGNANCY IN SUSPICIOUS BILIARY BRUSH CYTOLOGY
188. Elevated rates of horizontal gene transfer in the industrialized human microbiome
189. Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America
190. Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study
191. Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States
192. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
193. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis.
194. Biphenotypic hepatic tumors: imaging findings and review of literature
195. Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
196. Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?
197. Comparison of Methods to Detect Neoplasia in Patients Undergoing Endoscopic Ultrasound-Guided Fine-Needle Aspiration
198. Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
199. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
200. 310 Transcriptomics for gallbladder cancer prognosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.